• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

益生菌乳酸菌对肠道致病菌的体外抑菌作用与体内保护作用缺乏相关性。

Lack of correlation between in vitro antibiosis and in vivo protection against enteropathogenic bacteria by probiotic lactobacilli.

机构信息

Department of Microbiology, Faculty of Pharmacy, University of Granada, 18071 Granada, Spain.

Department of Nutrition and Bromatology, Faculty of Pharmacy, University of Granada, 18071 Granada, Spain.

出版信息

Res Microbiol. 2014 Jan;165(1):14-20. doi: 10.1016/j.resmic.2013.10.006. Epub 2013 Oct 17.

DOI:10.1016/j.resmic.2013.10.006
PMID:24140789
Abstract

Increased resistance to infection is one of the beneficial effects attributed to probiotic microorganisms. This effect may be due to several mechanisms: production of inhibitory substances, blocking of adhesion sites on the intestinal surface, competition for nutrients and stimulation of mucosal and systemic immunity. The present study aimed to investigate the correlation between in vitro and in vivo antimicrobial activity of probiotic lactobacilli. The agar spot test was used to show that twenty Lactobacillus strains were able to inhibit the enteropathogenic bacterium Yersinia enterocolitica. This inhibition was mainly attributable to a decrease in pH resulting from dextrose fermentation by lactobacilli. The inhibition of Y. enterocolitica, Salmonella enterica serovar Typhimurium and Listeria monocytogenes by two probiotic strains, Lactobacillus casei C1 and Lactobacillus plantarum C4, was also associated with the pH decrease. However, both strains lacked protective effects in mouse experimental infection models, with the exception of long-lasting pre-treatment with L. plantarum C4, which exerted a partial protective effect against S. Typhimurium that was attributable to an immunostimulatory mechanism. Our results show that in vitro antibiosis tests do not provide useful information on the probiotic potential of Lactobacillus strains.

摘要

增强抗感染能力是益生菌微生物的有益作用之一。这种作用可能是由于几种机制:产生抑制物质、阻断肠道表面的粘附位点、竞争营养物质和刺激黏膜和全身免疫。本研究旨在研究益生菌乳杆菌的体外和体内抗菌活性之间的相关性。琼脂点试验表明,二十株乳杆菌能够抑制肠道致病菌耶尔森氏菌。这种抑制主要归因于乳杆菌通过发酵葡萄糖导致 pH 值下降。两种益生菌菌株——干酪乳杆菌 C1 和植物乳杆菌 C4 对肠炎沙门氏菌 Typhimurium 和李斯特菌的抑制作用也与 pH 值下降有关。然而,除了植物乳杆菌 C4 的长期预处理外,这两种菌株在小鼠实验感染模型中均没有保护作用,而植物乳杆菌 C4 的预处理对肠炎沙门氏菌具有部分保护作用,这归因于免疫刺激机制。我们的结果表明,体外抑菌试验不能为乳杆菌菌株的益生菌潜力提供有用信息。

相似文献

1
Lack of correlation between in vitro antibiosis and in vivo protection against enteropathogenic bacteria by probiotic lactobacilli.益生菌乳酸菌对肠道致病菌的体外抑菌作用与体内保护作用缺乏相关性。
Res Microbiol. 2014 Jan;165(1):14-20. doi: 10.1016/j.resmic.2013.10.006. Epub 2013 Oct 17.
2
Antibacterial activity of Lactobacillus spp. isolated from the feces of healthy infants against enteropathogenic bacteria.从健康婴儿粪便中分离出的乳酸杆菌属对肠道致病菌的抗菌活性。
Anaerobe. 2015 Aug;34:53-8. doi: 10.1016/j.anaerobe.2015.04.014. Epub 2015 Apr 28.
3
pH-, Lactic acid-, and non-lactic acid-dependent activities of probiotic Lactobacilli against Salmonella enterica Serovar Typhimurium.益生菌乳酸杆菌对肠炎沙门氏菌鼠伤寒血清型的pH值、乳酸和非乳酸依赖性活性。
Appl Environ Microbiol. 2005 Oct;71(10):6008-13. doi: 10.1128/AEM.71.10.6008-6013.2005.
4
Subtractive screening for probiotic properties of lactobacillus species from the human gastrointestinal tract in the search for new probiotics.从人类胃肠道中筛选具有益生菌特性的乳酸杆菌属物种以寻找新型益生菌的消减筛选法。
J Food Sci. 2007 Oct;72(8):M310-5. doi: 10.1111/j.1750-3841.2007.00479.x.
5
Probiotic properties of Lactobacillus strains isolated from the feces of breast-fed infants and Taiwanese pickled cabbage.从母乳喂养婴儿的粪便和台湾酸菜中分离出的乳酸菌的益生菌特性。
Anaerobe. 2010 Dec;16(6):578-85. doi: 10.1016/j.anaerobe.2010.10.003. Epub 2010 Oct 15.
6
In vitro characterization of aggregation and adhesion properties of viable and heat-killed forms of two probiotic Lactobacillus strains and interaction with foodborne zoonotic bacteria, especially Campylobacter jejuni.体外鉴定两种益生菌乳杆菌活菌和热死菌的聚集和黏附特性及其与食源性病原体细菌,特别是空肠弯曲菌的相互作用。
J Med Microbiol. 2013 Apr;62(Pt 4):637-649. doi: 10.1099/jmm.0.049965-0. Epub 2013 Jan 17.
7
Selection of potential probiotic lactobacilli from pig feces to be used as additives in pelleted feeding.从猪粪便中筛选潜在的益生菌乳酸杆菌用作颗粒饲料添加剂。
Res Microbiol. 2006 Oct;157(8):792-801. doi: 10.1016/j.resmic.2006.05.003. Epub 2006 Jun 23.
8
In vitro assessment of functional properties of lactic acid bacteria isolated from faecal microbiota of healthy dogs for potential use as probiotics.从健康犬粪便微生物群中分离的乳酸菌的体外功能特性评估,以潜在用作益生菌。
Benef Microbes. 2013 Sep;4(3):267-75. doi: 10.3920/BM2012.0048.
9
The Lactobacillus plantarum strain ACA-DC287 isolated from a Greek cheese demonstrates antagonistic activity in vitro and in vivo against Salmonella enterica serovar Typhimurium.从希腊奶酪中分离出的植物乳杆菌菌株ACA-DC287在体外和体内均表现出对鼠伤寒沙门氏菌的拮抗活性。
J Appl Microbiol. 2007 Sep;103(3):657-65. doi: 10.1111/j.1365-2672.2007.03293.x.
10
Role of probiotics in the prevention and treatment of meticillin-resistant Staphylococcus aureus infections.益生菌在耐甲氧西林金黄色葡萄球菌感染的预防和治疗中的作用。
Int J Antimicrob Agents. 2013 Dec;42(6):475-81. doi: 10.1016/j.ijantimicag.2013.08.003. Epub 2013 Sep 7.

引用本文的文献

1
Novel Dietary Approach with Probiotics, Prebiotics, and Synbiotics to Mitigate Antimicrobial Resistance and Subsequent Out Marketplace of Antimicrobial Agents: A Review.采用益生菌、益生元及合生元的新型饮食方法减轻抗生素耐药性及后续抗菌药物退出市场:综述
Infect Drug Resist. 2023 May 23;16:3191-3211. doi: 10.2147/IDR.S413416. eCollection 2023.
2
Characterization and evaluation of the cholesterol-lowering ability of Lactiplantibacillus plantarum HJ-S2 isolated from the intestine of Mesoplodon densirostris.从抹香鲸肠道中分离的植物乳杆菌 HJ-S2 的降胆固醇能力的特性描述和评估。
World J Microbiol Biotechnol. 2023 May 17;39(8):199. doi: 10.1007/s11274-023-03637-w.
3
Yersinia enterocolitica in Crohn's disease.
克罗恩病中的小肠结肠炎耶尔森菌。
Front Cell Infect Microbiol. 2023 Mar 8;13:1129996. doi: 10.3389/fcimb.2023.1129996. eCollection 2023.
4
Protective Effect of Levilactobacillus brevis Against Yersinia enterocolitica Infection in Mouse Model via Regulating MAPK and NF-κB Pathway.短双歧杆菌通过调节 MAPK 和 NF-κB 通路对鼠伤寒沙门氏菌感染的保护作用。
Probiotics Antimicrob Proteins. 2022 Oct;14(5):830-844. doi: 10.1007/s12602-022-09957-x. Epub 2022 Jun 4.
5
Terminal Ileitis due to Infection: An Underdiagnosed Situation.感染致末端回肠炎:一种被低估的情况。
Biomed Res Int. 2020 May 23;2020:1240626. doi: 10.1155/2020/1240626. eCollection 2020.
6
KLDS1.0318 Ameliorates Impaired Intestinal Immunity and Metabolic Disorders in Cyclophosphamide-Treated Mice.KLDS1.0318改善环磷酰胺处理小鼠的肠道免疫损伤和代谢紊乱。
Front Microbiol. 2019 Apr 12;10:731. doi: 10.3389/fmicb.2019.00731. eCollection 2019.
7
Antilisterial efficacy of Lactobacillus brevis MF179529 from cow: an in vivo evidence.短乳杆菌 MF179529 对奶牛源李斯特菌的抑菌效果:体内证据。
BMC Complement Altern Med. 2019 Feb 1;19(1):37. doi: 10.1186/s12906-019-2444-5.
8
Mixed Strains Inhibit Induced Inflammation and Ameliorate Intestinal Microflora in Mice.混合菌株可抑制小鼠诱导性炎症并改善肠道微生物群。
Biomed Res Int. 2017;2017:7476467. doi: 10.1155/2017/7476467. Epub 2017 Jul 27.
9
Can probiotics modulate human disease by impacting intestinal barrier function?益生菌能否通过影响肠道屏障功能来调节人类疾病?
Br J Nutr. 2017 Jan;117(1):93-107. doi: 10.1017/S0007114516004037.
10
Macrophages Are Involved in Gut Bacterial Translocation and Reversed by Lactobacillus in Experimental Uremia.巨噬细胞参与实验性尿毒症中肠道细菌移位,且被乳酸杆菌逆转。
Dig Dis Sci. 2016 Jun;61(6):1534-44. doi: 10.1007/s10620-015-3950-z. Epub 2015 Oct 30.